{"id":"W2576905928","doi":"10.1016/j.leukres.2017.01.005","title":"Current approach to the treatment of chronic myeloid leukaemia","year":2017,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Ponatinib; Hematologist; Imatinib; Intensive care medicine; Imatinib mesylate; Chronic myeloid leukaemia; Oncology; Myeloid leukemia; Immunology; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001637941,0.001053026,0.003995199,0.0009668755,0.0006612171,0.0001439645,0.001921846,0.0006884836,0.0001525807],"category_scores_gemma":[0.0004355614,0.0005875024,0.001537236,0.001079363,0.0006772351,0.00007932051,0.0005459889,0.002012247,0.001965686],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05763966,"about_ca_system_score_gemma":0.02792252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008714272,"about_ca_topic_score_gemma":0.00008285061,"domain_scores_codex":[0.9922735,0.0008040612,0.001300354,0.001575885,0.002313876,0.001732295],"domain_scores_gemma":[0.9919732,0.000800959,0.000545453,0.005482792,0.0004730968,0.0007244522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007333628,0.0009233738,0.000008499434,0.02035229,0.0008387598,0.00007051055,0.000305281,0.00000599413,0.000001133801,0.0001682239,0.0113774,0.9658752],"study_design_scores_gemma":[0.002548854,0.002048567,0.00003126239,0.01473195,0.001361241,0.0002368662,0.00002730112,0.0001004487,0.00002184709,0.00001304146,0.9784803,0.000398297],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008228351,0.9748484,0.00001789159,0.0001167743,0.0005046924,0.008701473,0.0001584573,0.00006831779,0.01550165],"genre_scores_gemma":[0.00009183008,0.9798663,0.0002120274,0.000008686356,0.002498755,0.003643146,0.0006028092,0.0002203871,0.01285602],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9671029,"threshold_uncertainty_score":0.9996576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3100638100786055,"score_gpt":0.4895030462241493,"score_spread":0.1794392361455439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}